BioWorld

Dec. 8, 2008

Deerfield Counters Proposed NitroMed-Archemix Merger

NitroMed Inc. shareholder Deerfield Management is less than thrilled with the company's plan to serve as a public shell for a reverse merger with privately held Archemix Corp. (BioWorld Today) Read More

Stupak Urges Obama to Go Outside the FDA for New Chief

Study Shows How Gene Variation Affects Anemia

ISTA's Phase III Eye Drug Study Region Showed Skewed Results

Departing Execs, Halted Trials Send Orexigen Shares Falling

Other News To Note

Clinic Roundup

Appointments And Advancements

Financings Roundup

Today's news in brief

BioWorld

BioWorld briefs for June 18, 2025.

Today's news in brief

BioWorld MedTech

BioWorld MedTech briefs for June 18, 2025.

An early stage 85% remissions rate in AML drives Aptevo’s stock surge

BioWorld

An 85% remissions rate was found in updated results from Aptevo Therapeutics Inc.’s ongoing phase Ib/II Ranier study of mipletamig in one of the toughest blood...

BIO 2025: Makary lays out FDA’s path, launches pilot review program

BioWorld

On the same day that FDA Commissioner Martin Makary spoke in a fireside chat during the 2025 Biotechnology Innovation Organization’s International Convention, the...

3D illustration of a chain of amino acid or biomolecules called protein

Alphadesign: AI creating proteins from scratch

BioWorld Science

The Alphafold machine learning system for predicting a protein’s structure from its amino acid sequence has been adapted to make it possible to design de novo...